Can a new MS drug help patients walk better?
NCT ID NCT04387734
Summary
This study aims to see if the drug Ocrevus helps people with relapsing multiple sclerosis walk better compared to other standard MS medications. Sixty participants will be split into two groups—one receiving Ocrevus and the other receiving a different MS drug—for one year. Researchers will measure walking ability, balance, and leg strength several times and use brain scans to look for changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Georgia State University
Atlanta, Georgia, 30303, United States
-
Multiple Sclerosis Center of Atlanta
Atlanta, Georgia, 30327, United States
Conditions
Explore the condition pages connected to this study.